A research investigation conducted on needle biopsy specimens taken from hypothalamic hamartoma cells, which is believed to be an inherent component of epilepsy, discovered a reduction in nuclear immunostaining of ADAR2 together with a decline in RNA editing effectiveness at the GluA2 Q/R site (Kitaura et al., 2017[55]). The gene discussed is GRIA2; the disease is epilepsy.